Additional and future studies are warranted to identify the complete TRIM21 ubiquitination target network and to investigate the long-term and dose-dependent activation and silencing of TRIM21 in hepatocytes as well as KCs. The gene discussed is TRIM21; the disease is dry eye syndrome.